1. Societal preference values for advanced melanoma health states in the United Kingdom and Australia.
- Author
-
Beusterien, K. M., Szabo, S. M., Kotapati, S., Mukherjee, J., Hoos, A., Hersey, P., Middleton, M. R., and Levy, A. R.
- Subjects
- *
MELANOMA treatment , *PREFERENCES (Philosophy) , *COST effectiveness , *VALUE engineering , *THERAPEUTICS , *ANTINEOPLASTIC agents , *COMPARATIVE studies , *HEALTH status indicators , *RESEARCH methodology , *MEDICAL cooperation , *MELANOMA , *RESEARCH , *EVALUATION research , *CROSS-sectional method - Abstract
Background: No studies measure preference-based utilities in advanced melanoma that capture both intended clinical response and unintended toxicities associated with treatment.Methods: Using standard gamble, utilities were elicited from 140 respondents in the United Kingdom and Australia for 13 health states.Results: Preferences decreased with reduced treatment responsiveness and with increasing toxicity.Conclusions: These general population utilities can be incorporated into treatment-specific cost-effectiveness evaluations. [ABSTRACT FROM AUTHOR]- Published
- 2009
- Full Text
- View/download PDF